Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Yamaoka

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of the Neurological Sciences|May 1, 1982
Myotonic muscular dystrophy. Calcium-dependent phosphatidate metabolism in the erythrocyte membraneL H Yamaoka, J M Vance, A D Roses
Clinical Genetics|June 1, 1989
Duchenne muscular dystrophy: detection of deletion carriers by spectrophotometric densitometryN G Laing, T Siddique, R Bartlett, et al.
Human Heredity|November 14, 1998
Evidence for genetic heterogeneity supports clinical differences in congenital myasthenic syndromesM M Menold, M Sadeh, F Lennon, et al.
Genomics|April 7, 1999
A radiation hybrid breakpoint map of the acute myeloid leukemia (AML) and limb-girdle muscular dystrophy 1A (LGMD1A) regions of chromosome 5q31 localizing 122 expressed sequencesS K Horrigan, L Bartoloni, M C Speer, et al.
Genomics|October 1, 1993
Genetic and physical mapping of the Treacher Collins syndrome locus with respect to loci in the chromosome 5q3 regionE W Jabs, X Li, M Lovett, et al.
Muscle & Nerve|June 1, 1983
Recombinant DNA strategies in genetic neurological diseasesA D Roses, M A Pericak-Vance, L H Yamaoka, et al.
Genomics|April 1, 1991
Localization of Charcot-Marie-Tooth disease type 1a (CMT1A) to chromosome 17p11.2J M Vance, D Barker, L H Yamaoka, et al.
Genomics|March 1, 1990
Confirmation of linkage in von Hippel-Lindau diseaseJ M Vance, K W Small, M A Jones, et al.
Cytogenetics and Cell Genetics|January 1, 1994
Physical and genetic map of 5q31: use of fluorescence in situ hybridization data to identify errors in the CEPH database. Centre d'Etude de Polymorphisme HumainC A Westbrook, M M Le Beau, W L Neuman, et al.
Neurology|March 1, 1992
Linkage studies in Charcot-Marie-Tooth disease type 2: evidence that CMT types 1 and 2 are distinct genetic entitiesL J Loprest, M A Pericak-Vance, J Stajich, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of the Neurological Sciences|May 1, 1982
Myotonic muscular dystrophy. Calcium-dependent phosphatidate metabolism in the erythrocyte membraneL H Yamaoka, J M Vance, A D Roses
Clinical Genetics|June 1, 1989
Duchenne muscular dystrophy: detection of deletion carriers by spectrophotometric densitometryN G Laing, T Siddique, R Bartlett, et al.
Human Heredity|November 14, 1998
Evidence for genetic heterogeneity supports clinical differences in congenital myasthenic syndromesM M Menold, M Sadeh, F Lennon, et al.
Genomics|April 7, 1999
A radiation hybrid breakpoint map of the acute myeloid leukemia (AML) and limb-girdle muscular dystrophy 1A (LGMD1A) regions of chromosome 5q31 localizing 122 expressed sequencesS K Horrigan, L Bartoloni, M C Speer, et al.
Genomics|October 1, 1993
Genetic and physical mapping of the Treacher Collins syndrome locus with respect to loci in the chromosome 5q3 regionE W Jabs, X Li, M Lovett, et al.
Muscle & Nerve|June 1, 1983
Recombinant DNA strategies in genetic neurological diseasesA D Roses, M A Pericak-Vance, L H Yamaoka, et al.
Genomics|April 1, 1991
Localization of Charcot-Marie-Tooth disease type 1a (CMT1A) to chromosome 17p11.2J M Vance, D Barker, L H Yamaoka, et al.
Genomics|March 1, 1990
Confirmation of linkage in von Hippel-Lindau diseaseJ M Vance, K W Small, M A Jones, et al.
Cytogenetics and Cell Genetics|January 1, 1994
Physical and genetic map of 5q31: use of fluorescence in situ hybridization data to identify errors in the CEPH database. Centre d'Etude de Polymorphisme HumainC A Westbrook, M M Le Beau, W L Neuman, et al.
Neurology|March 1, 1992
Linkage studies in Charcot-Marie-Tooth disease type 2: evidence that CMT types 1 and 2 are distinct genetic entitiesL J Loprest, M A Pericak-Vance, J Stajich, et al.
Pageof 5